46 evolution "https:" "https:" "https:" "https:" "https:" "https:" "University of Warwick" research jobs at University of London
Sort by
Refine Your Search
-
About the Role Postdoctoral Research Assistant to join Dr Diu Nguyen’s group (https://www.diunguyenlab.org/). We study the biological mechanisms underpinning leukaemia development and progression
-
. The goals are to develop a greater understanding of basic mechanisms of immunological protection versus pathology, and to apply this knowledge to the development of interventions and the identification
-
on the development, validation and use of organ-chip models. We are particularly focused on the development and use of joint-on-a-chip models including synovium, bone, cartilage, fat along with inflammatory components
-
collection and analysis, the development of academic publications as well as engagement and dissemination activities. We seek a passionate, effective and collegial person to join our interdisciplinary team
-
efficient running of laboratory operations to support both ongoing projects and the development of early-career researchers. About the School/Department/Institute/Project Located at the Charterhouse Square
-
responsibility for the development of the simulations but will contribute to all aspects of the project in collaboration with the PI and a PhD student to be funded by the grant. About You The successful candidate
-
About the Role We are seeking a postdoctoral research assistant to join the group of Dr Mirjana Efremova in the Centre for Cancer Evolution, to investigate epigenetic regulators driving therapy
-
About the Role You will contribute to the construction and quality control of the ATLAS Inner Tracker (ITk). The ITk group at Queen Mary University of London has played a key role in the development
-
the design, development, deployment and evaluation of NeoShield’s applied machine-learning systems, the machine-learning-driven Clinical Decision Support Algorithm for neonatal sepsis and the real-time ward
-
our team and help in the development of a new class of precision therapies that remodel the tumour extracellular matrix (ECM) to convert immune-excluded tumours into therapy-responsive ones. These ECM